Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | XmAb808 |
Trade Name | |
Synonyms | XmAb-808|XmAb 808 |
Drug Descriptions |
Limited information is currently available on XmAb808, a putative bispecific antibody targeting B7-H3 (CD276) and CD28 (Apr 2023). |
DrugClasses | CD276 Antibody 12 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + XmAb808 | Pembrolizumab XmAb808 | 0 | 1 |
XmAb808 | XmAb808 | 0 | 0 |